BRANFORD, Conn., Nov. 2 /PRNewswire-FirstCall/ -- CuraGen Corporation announced today that Timothy M. Shannon, M.D., Executive Vice President of Research and Development and Chief Medical Officer, and David M. Wurzer, Executive Vice President and Chief Financial Officer, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference. The presentation will take place at 10:50 a.m. Eastern time on Wednesday, November 9, 2005 at the New York Palace Hotel in New York City.
The management team will provide an overview of the Company and review the progress CuraGen is making toward advancing its pipeline of potential protein, antibody, and small molecule therapeutics.
Access to a live webcast of the presentation will be available at http://www.curagen.com. A replay of the webcast will be accessible following the presentation and archived for 30 days thereafter.
Rodman & Renshaw Techvest 7th Annual Healthcare Conference will be held on November 7-9, 2005 at the New York Palace Hotel in New York City. The three- day conference explores advancements in a number of therapeutic areas including oncology, cardiovascular disease, medical device technology and infectious diseases, and brings together members of the life sciences and investment communities through a series of presentations, breakout sessions, and one-on-one informational meetings.
About CuraGen
CuraGen Corporation is a biopharmaceutical company dedicated to improving the lives of patients by developing a pipeline of novel protein, antibody, and small molecule therapeutics in the areas of oncology, inflammatory diseases, and diabetes. CuraGen has established broad development alliances with Abgenix, TopoTarget, and Bayer, and its experienced preclinical and clinical teams are advancing the Company's pipeline of products for unmet medical needs. The Company is headquartered in Branford, CT. For additional information please visit http://www.curagen.com.
Contact: Glenn Schulman, Pharm.D. Assistant Director of Investor Relations gschulman@curagen.com (888) 436-6642
CuraGen CorporationCONTACT: Glenn Schulman, Pharm.D., Assistant Director of InvestorRelations of CuraGen Corporation, gschulman@curagen.com, or +1-888-436-6642
Web site: http://www.curagen.com//
